Bedel Financial Consulting, Inc. Iterum Therapeutics PLC Put Options Transaction History
Bedel Financial Consulting, Inc.
- $691 Million
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding ITRM
# of Institutions
1Shares Held
66Call Options Held
0Put Options Held
0About Iterum Therapeutics plc
- Ticker ITRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,233,400
- Market Cap $13.7M
- Description
- Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...